Novo Nordisk has stated that its flagship insulin brand Mixtard will continue to be available in India in vial form, even as the company phases out other delivery formats such as Penfill cartridges.

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

Denmark-based global pharma major, Novo Nordisk is now phasing out its Human Mixtard penfill by the year end. However Mixtard in India will continue to be available in vials. Along with it, other form ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard ...

India’s diabetic population, particularly those on Novo Nordisk’s Human Mixtard insulin, are now apprehensive regarding changes in prescription practices. These concerns are attributed to various ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...